ETFS Holding Cubist Pharmaceuticals, Inc.

 
ETF Quotes for ETFS Holding Cubist Pharmaceuticals, Inc. top ^
  • Holdings: Alkermes PLC , Cooper Companies , Cubist Pharmaceuticals Inc , Harman International Industries Inc , Isis Pharmaceuticals ,
  • Morningstar Rating: 4 Stars
Sign-up for vbk investment picks
  • Holdings: Cubist Pharmaceuticals Inc , Baker Hughes Inc , Allergan Inc , Time Warner Cable Inc , Directv ,
  • Morningstar Rating: 4 Stars
Sign-up for mna investment picks

 
Stock Quotes for Cubist Pharmaceuticals, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Speculative Growth
  • Morningstar Rating: 3 Stars
Sign-up for cbst investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Speculative Growth
  • Morningstar Rating: 3 Stars
Sign-up for cbst investment picks

 
News Articles for Cubist Pharmaceuticals, Inc. top ^
2014/12/10
Levi & Korsinsky is investigating the Board of Directors of Cubist Pharmaceuticals, Inc. (“Cubist Pharmaceuticals” or “the Company”) (NasdaqGS:CBST) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Merck & Co.
Sign-up for CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co. investment picks
NEW YORK , Dec.
Sign-up for Harwood Feffer LLP Announces Investigation of Cubist Pharmaceuticals Inc. investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cubist Pharmaceuticals, Inc. (“Cubist” or the “Company”) (Nasdaq: CBST) relating to the proposed buyout of the Company by Merck & Co., Inc. (“Merck”). On December 8, 2014, Cubist and Merck announced the signing of a definitive agreement pursuant to which Merck will acquire Cubist in a transaction valued at approximately $9.5 billion.
Sign-up for SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information investment picks
2014/12/8
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cubist Pharmaceuticals, Inc. (“Cubist”) (NASDAQ GS:CBST) concerning the sale to Merck & Co., Inc. Under the terms of the agreement, Cubist shareholders will receive $102.00 in cash for each share owned, which is only a 37% premium over the share price just before the deal was announced and only a slight premium over the 52-week high.
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck & Co., Inc. investment picks
2014/12/8
WILMINGTON, Del.
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) breached their fiduciary duties in connection with the planned merger of the Company with Merck & Co., Inc. Cubist is engaged in the research, development, and commercialization of pharmaceutical products for medical needs in the acute care environment.
Sign-up for CUBIST PHARMACEUTICALS ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Cubist Pharmaceuticals, Inc. to Merck investment picks
2014/12/8
By Peter Loftus and Dana CimillucaThe per-share bid of $102 is 37% above Friday's closing price of Cubist's stock Drug giant Merck & Co.
Sign-up for Merck to buy Cubist Pharmaceuticals for $8.4 billion investment picks
Cubist Pharmaceuticals (CBST) announced on Monday an agreement to be acquired by Merck & Co.
Sign-up for Merck to buy Cubist Pharmaceuticals in $9.5 billion deal investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the companies have entered into a definitive agreement under which Merck will acquire Cubist for $102 per share in cash, which represents a 35 percent premium to Cubist’s average stock price for the most recent five trading days.
Sign-up for Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cubist Pharmaceuticals NEW YORK , Dec.
Sign-up for CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc. - CBST investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Cubist Pharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Cubesmart  |  Next: ETFS Holding Cummins Inc